Cervical cancer trials in Netherlands

In Netherlands 19 Also abroad 532

19 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
Phase 1/2Taking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
Age
18 years and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
No phaseTaking people
Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy
Where
Rotterdam
Age
18 years and over
People
25
Run by
Erasmus Medical Center
See details and how to joinNCT07435987
No phaseTaking people
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Where
Amsterdam
Age
18 years and over
People
27
Run by
Amsterdam UMC, location VUmc
See details and how to joinNCT07782164
Phase 2Taking people
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
Where
Amsterdam
Age
18 years and over
People
24 worldwide
Run by
Vall D Hebron Institute Of Oncology
See details and how to join2023-506400-99-00 · EU 2023-506400-99-00
Phase 1/2Taking people
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Where
Amsterdam, Rotterdam
Age
18 years and over
People
880 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00
Phase 4Taking people
Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Where
Amsterdam, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht, Zwolle
Age
18 years and over
People
261
Run by
University Medical Center Groningen
See details and how to joinNCT07645625
Phase 1Taking people
Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC)
Where
Groningen
Age
18 years and over
People
12
Run by
University Medical Center Groningen
See details and how to joinNCT07653503
Phase 1Taking people
A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors
Where
Amsterdam, Nijmegen
Age
18 years and over
People
21
Run by
Merck Sharp & Dohme LLC
See details and how to join2024-516870-31-00 · EU 2024-516870-31-00
Phase 4Taking people
PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Where
Amsterdam, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht, Zwolle
Age
18 years and over
People
261
Run by
Universitair Medisch Centrum Groningen
See details and how to join2025-522883-34-00 · EU 2025-522883-34-00
Phase 2Not yet taking people in Netherlands
Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
Where
Rotterdam
Age
18 years and over
People
87
Run by
Prof. Dr. Remi A. Nout
See details and how to joinNCT07368985 · EU 2023-506982-73-00
Phase 1Taking people
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer
Where
Groningen
Age
18 years and over
People
12
Run by
Universitair Medisch Centrum Groningen
See details and how to join2025-521771-31-00 · EU 2025-521771-31-00
Phase 2Taking people
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
Where
Amsterdam, Eindhoven, Groningen, Leiden, Maastricht, Nijmegen, Utrecht
Age
18 years to 40 years
People
31 worldwide
Run by
University Health Network, Toronto
See details and how to joinNCT04016389 · EU 2023-507230-24-00
No phaseTaking people
Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
Where
Amsterdam
Age
18 years and over
People
100
Run by
The Netherlands Cancer Institute
See details and how to joinNCT06691776
No phaseTaking people
Early Ageing During Therapy in AYA Cancer Patients
Where
Groningen
Age
18 years to 39 years
People
120
Run by
University Medical Center Groningen
See details and how to joinNCT05062707
No phaseTaking people
Standard Follow-up Program Cervix Cancer (SFP CERVIX)
Where
Groningen
People
10,000
Run by
University Medical Center Groningen
See details and how to joinNCT02733289
No phaseTaking people
Distress In CErvical Cancer Patients and Partners
Where
Breda, Eindhoven, Groningen, Maastricht, Nijmegen, Utrecht
Age
18 years and over
People
832
Run by
Comprehensive Cancer Centre The Netherlands
See details and how to joinNCT04475354
No phaseTaking people
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
Where
Leiden, Rotterdam
Age
18 years and over
People
30
Run by
Leiden University Medical Center
See details and how to joinNCT05406856
No phaseTaking people
MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA)
Where
Utrecht
Age
18 years and over
People
30 worldwide
Run by
UMC Utrecht
See details and how to joinNCT05937958